Evome Medical Technologies Profit Margin

Evome Medical Technologies (LNDZF) currently reports a profit margin of -2.3% as of September 2023. That compares with -45.66% in the prior-year period — up 95.0% year over year. That is below the sector sector average of 13.78%. Use the charts on this page to explore Evome Medical Technologies's profit margin history and peer comparisons.

Evome Medical Technologies's profit margin increased from -45.66% to -2.3% — a 95.0% year-over-year increase (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Evome Medical Technologies's profit margin of -2.3% is lower than the its sector sector average of 13.78%. That is roughly 116.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Evome Medical Technologies's current -2.3% should be judged against industry norms (sector average: 13.78%) and against LNDZF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -2.3%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.78%. From there, open related valuation or income-statement pages for Evome Medical Technologies, and consider following LNDZF for alerts when major investors trade the stock.